Zobrazeno 1 - 10
of 43
pro vyhledávání: '"Pål Stenberg"'
Publikováno v:
Journal of Translational Autoimmunity, Vol 4, Iss , Pp 100110- (2021)
For a whole century, citrate has been used as an in vitro anticoagulant via chelation of calcium. Later, also EDTA was introduced as an anticoagulant. An often overlooked fact is that zinc is bound to citrate and EDTA with affinities much greater tha
Externí odkaz:
https://doaj.org/article/49974f6c3e004081ba4c77cfad291a5d
Publikováno v:
Journal of Translational Autoimmunity
Journal of Translational Autoimmunity, Vol 4, Iss, Pp 100110-(2021)
Journal of Translational Autoimmunity, Vol 4, Iss, Pp 100110-(2021)
For a whole century, citrate has been used as an in vitro anticoagulant via chelation of calcium. Later, also EDTA was introduced as an anticoagulant. An often overlooked fact is that zinc is bound to citrate and EDTA with affinities much greater tha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c5f39e79bbcbf677e5396abf2dc55bdb
http://europepmc.org/articles/PMC8233124
http://europepmc.org/articles/PMC8233124
Autor:
Pål Stenberg, Bodil Roth
Publikováno v:
Medical Hypotheses; 84(4), pp 331-335 (2015)
Post-translational modifications of proteins can generate antigenic conformations that may cause autoimmune diseases in persons with specific HLA-haplotypes. Monocytes and macrophages, attracted to an inflamed site, can release post-translationally a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::29cfe2450092e3943eadc17fb3c7c219
https://doi.org/10.1016/j.mehy.2015.01.022
https://doi.org/10.1016/j.mehy.2015.01.022
Publikováno v:
European Journal of Internal Medicine. 20:749-755
Post-translational modifications are associated with certain autoimmune diseases. For example, in the initial steps of coeliac disease (CD), transglutaminase type 2 (TG2) catalyzes a post-translational deamidation of specific glutamine residues in di
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::224e93ace3a87f4e0a7b705a1efb4ccc
https://doi.org/10.1016/j.ejim.2009.08.007
https://doi.org/10.1016/j.ejim.2009.08.007
Publikováno v:
Scandinavian Journal of Haematology. 24:340-349
The in vitro properties of 5 factor VIII preparations (AHF-Kabi, Hemofil Hyland, AHF-Profilate Abbott, Kryobulin Immuno and Factorate High Purity Armour) and an ordinary cryoprecipitate were studied with reference to factor VIII clotting activity (VI
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bbc331e1bd72b7266b2c276ff9b25764
https://doi.org/10.1111/j.1600-0609.1980.tb01593.x
https://doi.org/10.1111/j.1600-0609.1980.tb01593.x
Publikováno v:
European Journal of Haematology. 46:263-271
There are divergent reports in the literature on the character of transglutaminases in monocytes and macrophages. The aim of the present study was to further elucidate the characteristics and functions of various transglutaminases in monocytes and ma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4ebe3e80e0e4f888a9521975010155d2
https://doi.org/10.1111/j.1600-0609.1991.tb01537.x
https://doi.org/10.1111/j.1600-0609.1991.tb01537.x
Autor:
Elke Theander, E. Bodil Roth, Anna-Maria Larsson, Pål Stenberg, Klas Sjöberg, M. Sandberg-Wollheim, E. Londos
Publikováno v:
Scandinavian Journal of Immunology. 67:626-631
Coeliac disease (CD) is becoming a model for understanding the pathogenesis of autoimmune disorders. In CD, antibodies against transglutaminase 2 (TG2) and specific residues of gliadins have been identified. A similar situation is seen in rheumatoid
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::52dbdb62cc610bf482a3f750b49e483a
https://doi.org/10.1111/j.1365-3083.2008.02115.x
https://doi.org/10.1111/j.1365-3083.2008.02115.x
Publikováno v:
European Journal of Internal Medicine. 19:83-91
In 1997, a German group demonstrated that the antigen of the biomarker EMA (endomysial antibodies) in coeliac disease is a calcium-dependent thiol enzyme, transglutaminase type 2 (TG2). This most important discovery opened up an exciting field of res
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::60ed80be8e759ea62f2ff1fdddd58f95
https://doi.org/10.1016/j.ejim.2007.05.012
https://doi.org/10.1016/j.ejim.2007.05.012
Publikováno v:
Autoimmunity. 36:221-226
Tissue transglutaminase (tTg) has been identified as the major autoantigen in coeliac disease (CD). ELISA methods have been developed for measuring the autoantibody. There are divergent reports on the effects of calcium on the antibody binding to tTg
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2ce41cda53aec2a5e9855557fb48cf20
https://doi.org/10.1080/0891693031000118974
https://doi.org/10.1080/0891693031000118974
Autor:
G. Rametsteiner, Karin Henricson, Anders Carlsten, A. Wessling, Arne Melander, Pål Stenberg, Jonas Ranstam
Publikováno v:
European Journal of Clinical Pharmacology. 55:605-611
To assess (1) whether the utilisation of codeine or propoxyphene differs among the three major Swedish cities (Stockholm, Göteborg and Malmö) and between urban and semirural areas; (2) if so, whether it co-varies with the utilisation of other poten
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::03b96161871b92e6d3087a3c479e0ae7
https://doi.org/10.1007/s002280050680
https://doi.org/10.1007/s002280050680